ENTO
Entero Therapeutics
ENTO
ENTO
12 hedge funds and large institutions have $77K invested in Entero Therapeutics in 2023 Q3 according to their latest regulatory filings, with 6 funds opening new positions, 1 increasing their positions, 1 reducing their positions, and 2 closing their positions.
New
Increased
Maintained
Reduced
Closed
more first-time investments, than exits
New positions opened: | Existing positions closed:
more funds holding
Funds holding: →
more capital invested
Capital invested by funds: $ → $
more ownership
Funds ownership: →
0% more repeat investments, than reductions
Existing positions increased: 1 | Existing positions reduced: 1
Holders
12
Holding in Top 10
–
Calls
–
Puts
–
Top Buyers
| 1 | +$23.7K | |
| 2 | +$15K | |
| 3 | +$12.3K | |
| 4 |
OAC
OMERS Administration Corp
Toronto,
Ontario, Canada
|
+$8.64K |
| 5 |
HF
HRT Financial
New York
|
+$5K |
Top Sellers
| 1 | -$15K | |
| 2 | -$253 | |
| 3 | -$38 | |
| 4 |
KSWA
Kathleen S. Wright Associates
Pittsburgh,
Pennsylvania
|
-$35 |
| 5 |
CPG
Cornerstone Planning Group
Fairfield,
New Jersey
|
-$22 |